CD73/PD-1 targeting drug Fc-conjugate (Cidara Therapeutics)

N/A

Report date: 2025/06/11 10:26:26

Base Information

Drug NameCD73/PD-1 targeting drug Fc-conjugate (Cidara Therapeutics)

Drug Alias NameCD73 inhibitor/PD-1-001 drug Fc-conjugate (Cidara Therapeutics)CD73/PD-1 targeting DFC (Cidara Therapeutics)dual CD73 checkpoint inhibitor/PD-1 checkpoint inhibitor (Cidara Therapeutics)PD-1/CD73 FDC

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Protein drugs > Recombinant polypeptide

Mechanisms of ActionLeukocytes stimulantsT lymphocytes stimulantsImmunostimulants +[5]

TargetsProgrammed cell death protein 15'-nucleotidase

Therapy Area/IndicationsSolid tumoursColorectal Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesCidara Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesCidara Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsSolid tumoursColorectal Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A